nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.217	0.361	CbGaD
Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.185	0.308	CbGaD
Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.124	0.207	CbGaD
Phenoxybenzamine—SLC22A3—Metformin—polycystic ovary syndrome	0.124	0.475	CbGbCtD
Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.074	0.123	CbGaD
Phenoxybenzamine—SLC22A2—Metformin—polycystic ovary syndrome	0.0733	0.281	CbGbCtD
Phenoxybenzamine—SLC22A1—Metformin—polycystic ovary syndrome	0.0637	0.244	CbGbCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.00229	0.497	CcSEcCtD
Phenoxybenzamine—CYP3A4—urine—polycystic ovary syndrome	0.00114	0.043	CbGeAlD
Phenoxybenzamine—SLC22A3—embryo—polycystic ovary syndrome	0.000771	0.0291	CbGeAlD
Phenoxybenzamine—CALM3—adrenal cortex—polycystic ovary syndrome	0.000684	0.0258	CbGeAlD
Phenoxybenzamine—CALM2—embryo—polycystic ovary syndrome	0.000655	0.0248	CbGeAlD
Phenoxybenzamine—Nasal congestion—Metformin—polycystic ovary syndrome	0.000652	0.141	CcSEcCtD
Phenoxybenzamine—CALM1—embryo—polycystic ovary syndrome	0.000652	0.0246	CbGeAlD
Phenoxybenzamine—CALM3—endometrium—polycystic ovary syndrome	0.00061	0.0231	CbGeAlD
Phenoxybenzamine—SLC22A3—endometrium—polycystic ovary syndrome	0.000564	0.0213	CbGeAlD
Phenoxybenzamine—CALM3—uterus—polycystic ovary syndrome	0.000562	0.0213	CbGeAlD
Phenoxybenzamine—CALM3—pituitary gland—polycystic ovary syndrome	0.000552	0.0209	CbGeAlD
Phenoxybenzamine—CALM3—adipose tissue—polycystic ovary syndrome	0.00055	0.0208	CbGeAlD
Phenoxybenzamine—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000549	0.0207	CbGeAlD
Phenoxybenzamine—CALM2—adrenal cortex—polycystic ovary syndrome	0.000537	0.0203	CbGeAlD
Phenoxybenzamine—CALM1—adrenal cortex—polycystic ovary syndrome	0.000534	0.0202	CbGeAlD
Phenoxybenzamine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000532	0.0201	CbGeAlD
Phenoxybenzamine—SLC22A3—adipose tissue—polycystic ovary syndrome	0.000509	0.0192	CbGeAlD
Phenoxybenzamine—CALM3—adrenal gland—polycystic ovary syndrome	0.000493	0.0186	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000492	0.107	CcSEcCtD
Phenoxybenzamine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.00048	0.0181	CbGeAlD
Phenoxybenzamine—CALM2—endometrium—polycystic ovary syndrome	0.000479	0.0181	CbGeAlD
Phenoxybenzamine—CALM1—endometrium—polycystic ovary syndrome	0.000477	0.018	CbGeAlD
Phenoxybenzamine—CALM3—female gonad—polycystic ovary syndrome	0.00046	0.0174	CbGeAlD
Phenoxybenzamine—Drowsiness—Metformin—polycystic ovary syndrome	0.000458	0.0992	CcSEcCtD
Phenoxybenzamine—CALM3—vagina—polycystic ovary syndrome	0.000457	0.0173	CbGeAlD
Phenoxybenzamine—SLC22A3—adrenal gland—polycystic ovary syndrome	0.000456	0.0172	CbGeAlD
Phenoxybenzamine—SLC22A1—vagina—polycystic ovary syndrome	0.000442	0.0167	CbGeAlD
Phenoxybenzamine—CALM2—uterus—polycystic ovary syndrome	0.000442	0.0167	CbGeAlD
Phenoxybenzamine—CALM1—uterus—polycystic ovary syndrome	0.00044	0.0166	CbGeAlD
Phenoxybenzamine—Clomifene—CYP11A1—polycystic ovary syndrome	0.000436	0.218	CrCbGaD
Phenoxybenzamine—CALM2—pituitary gland—polycystic ovary syndrome	0.000434	0.0164	CbGeAlD
Phenoxybenzamine—CALM2—adipose tissue—polycystic ovary syndrome	0.000432	0.0163	CbGeAlD
Phenoxybenzamine—CALM1—pituitary gland—polycystic ovary syndrome	0.000432	0.0163	CbGeAlD
Phenoxybenzamine—CALM1—adipose tissue—polycystic ovary syndrome	0.00043	0.0163	CbGeAlD
Phenoxybenzamine—ADRA2C—endometrium—polycystic ovary syndrome	0.000428	0.0162	CbGeAlD
Phenoxybenzamine—SLC22A3—female gonad—polycystic ovary syndrome	0.000425	0.0161	CbGeAlD
Phenoxybenzamine—SLC22A3—vagina—polycystic ovary syndrome	0.000423	0.016	CbGeAlD
Phenoxybenzamine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000414	0.0156	CbGeAlD
Phenoxybenzamine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000405	0.0153	CbGeAlD
Phenoxybenzamine—SLC22A3—endocrine gland—polycystic ovary syndrome	0.000396	0.015	CbGeAlD
Phenoxybenzamine—ADRA2C—uterus—polycystic ovary syndrome	0.000395	0.0149	CbGeAlD
Phenoxybenzamine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000388	0.0147	CbGeAlD
Phenoxybenzamine—CALM2—adrenal gland—polycystic ovary syndrome	0.000387	0.0146	CbGeAlD
Phenoxybenzamine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000386	0.0146	CbGeAlD
Phenoxybenzamine—CALM1—adrenal gland—polycystic ovary syndrome	0.000386	0.0146	CbGeAlD
Phenoxybenzamine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000363	0.0137	CbGeAlD
Phenoxybenzamine—CALM2—female gonad—polycystic ovary syndrome	0.000361	0.0137	CbGeAlD
Phenoxybenzamine—CALM1—female gonad—polycystic ovary syndrome	0.00036	0.0136	CbGeAlD
Phenoxybenzamine—CALM2—vagina—polycystic ovary syndrome	0.000359	0.0136	CbGeAlD
Phenoxybenzamine—CALM1—vagina—polycystic ovary syndrome	0.000357	0.0135	CbGeAlD
Phenoxybenzamine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000346	0.0131	CbGeAlD
Phenoxybenzamine—ADRA2A—endometrium—polycystic ovary syndrome	0.000342	0.0129	CbGeAlD
Phenoxybenzamine—CALM2—endocrine gland—polycystic ovary syndrome	0.000336	0.0127	CbGeAlD
Phenoxybenzamine—CALM1—endocrine gland—polycystic ovary syndrome	0.000334	0.0126	CbGeAlD
Phenoxybenzamine—Modafinil—ADRA1B—polycystic ovary syndrome	0.00033	0.165	CrCbGaD
Phenoxybenzamine—ADRA2C—female gonad—polycystic ovary syndrome	0.000323	0.0122	CbGeAlD
Phenoxybenzamine—ADRA2C—vagina—polycystic ovary syndrome	0.000321	0.0121	CbGeAlD
Phenoxybenzamine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000315	0.0119	CbGeAlD
Phenoxybenzamine—ADRA2A—uterus—polycystic ovary syndrome	0.000315	0.0119	CbGeAlD
Phenoxybenzamine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000309	0.0117	CbGeAlD
Phenoxybenzamine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000308	0.0116	CbGeAlD
Phenoxybenzamine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000276	0.0104	CbGeAlD
Phenoxybenzamine—Somnolence—Metformin—polycystic ovary syndrome	0.00026	0.0563	CcSEcCtD
Phenoxybenzamine—ADRA2A—female gonad—polycystic ovary syndrome	0.000258	0.00974	CbGeAlD
Phenoxybenzamine—ADRA2A—vagina—polycystic ovary syndrome	0.000256	0.00968	CbGeAlD
Phenoxybenzamine—Fatigue—Metformin—polycystic ovary syndrome	0.000252	0.0546	CcSEcCtD
Phenoxybenzamine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.00024	0.00906	CbGeAlD
Phenoxybenzamine—Clomifene—CYP19A1—polycystic ovary syndrome	0.000226	0.113	CrCbGaD
Phenoxybenzamine—Asthenia—Metformin—polycystic ovary syndrome	0.00021	0.0454	CcSEcCtD
Phenoxybenzamine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.000193	0.0962	CrCbGaD
Phenoxybenzamine—Toremifene—CYP1A1—polycystic ovary syndrome	0.000192	0.0958	CrCbGaD
Phenoxybenzamine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000189	0.00713	CbGeAlD
Phenoxybenzamine—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.000176	0.088	CrCbGaD
Phenoxybenzamine—Clomifene—CYP1A1—polycystic ovary syndrome	0.000166	0.0828	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.000104	0.052	CrCbGaD
Phenoxybenzamine—Methadone—CYP19A1—polycystic ovary syndrome	0.000103	0.0516	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP1A1—polycystic ovary syndrome	7.67e-05	0.0383	CrCbGaD
Phenoxybenzamine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	4.1e-06	3.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—VEGFA—polycystic ovary syndrome	4.09e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	4.09e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ATF1—polycystic ovary syndrome	4.08e-06	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	4.07e-06	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRS2—polycystic ovary syndrome	4.06e-06	3.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CRP—polycystic ovary syndrome	4.06e-06	3.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.98e-06	3.74e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.96e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—VEGFA—polycystic ovary syndrome	3.96e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—VEGFA—polycystic ovary syndrome	3.96e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.94e-06	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.94e-06	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MTHFR—polycystic ovary syndrome	3.94e-06	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.94e-06	3.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CRP—polycystic ovary syndrome	3.93e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CRP—polycystic ovary syndrome	3.93e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRS2—polycystic ovary syndrome	3.93e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRS2—polycystic ovary syndrome	3.93e-06	3.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—GNAS—polycystic ovary syndrome	3.92e-06	3.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	3.88e-06	3.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.88e-06	3.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	3.87e-06	3.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.85e-06	3.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.85e-06	3.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MTHFR—polycystic ovary syndrome	3.82e-06	3.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MTHFR—polycystic ovary syndrome	3.82e-06	3.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	3.8e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—GNAS—polycystic ovary syndrome	3.8e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—GNAS—polycystic ovary syndrome	3.8e-06	3.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NGFR—polycystic ovary syndrome	3.76e-06	3.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IRS2—polycystic ovary syndrome	3.75e-06	3.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.75e-06	3.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—POMC—polycystic ovary syndrome	3.74e-06	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—NCOR1—polycystic ovary syndrome	3.74e-06	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PRL—polycystic ovary syndrome	3.73e-06	3.51e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	3.72e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	3.71e-06	3.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.69e-06	3.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	3.67e-06	3.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	3.67e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	3.67e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	3.64e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.64e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.64e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IRS2—polycystic ovary syndrome	3.63e-06	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IRS2—polycystic ovary syndrome	3.63e-06	3.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	3.62e-06	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.62e-06	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.62e-06	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.62e-06	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—NCOR1—polycystic ovary syndrome	3.62e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—NCOR1—polycystic ovary syndrome	3.62e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.62e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	3.61e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PRL—polycystic ovary syndrome	3.61e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PRL—polycystic ovary syndrome	3.61e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	3.6e-06	3.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.59e-06	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	3.56e-06	3.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRS1—polycystic ovary syndrome	3.55e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	3.55e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—INS—polycystic ovary syndrome	3.55e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CYP1A1—polycystic ovary syndrome	3.54e-06	3.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.54e-06	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	3.53e-06	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.53e-06	3.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	3.51e-06	3.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	3.49e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.48e-06	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.48e-06	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	3.47e-06	3.27e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	3.46e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRS1—polycystic ovary syndrome	3.43e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRS1—polycystic ovary syndrome	3.43e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CYP1A1—polycystic ovary syndrome	3.43e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CYP1A1—polycystic ovary syndrome	3.43e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.43e-06	3.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.42e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.42e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.42e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	3.42e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	3.41e-06	3.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	3.4e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	3.4e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	3.4e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.36e-06	3.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.31e-06	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—MTHFR—polycystic ovary syndrome	3.3e-06	3.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT2—polycystic ovary syndrome	3.28e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—GNAS—polycystic ovary syndrome	3.28e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IRS1—polycystic ovary syndrome	3.28e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.27e-06	3.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.23e-06	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—MTHFR—polycystic ovary syndrome	3.2e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—MTHFR—polycystic ovary syndrome	3.2e-06	3.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.19e-06	3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT2—polycystic ovary syndrome	3.18e-06	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT2—polycystic ovary syndrome	3.18e-06	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—GNAS—polycystic ovary syndrome	3.17e-06	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—GNAS—polycystic ovary syndrome	3.17e-06	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	3.17e-06	2.99e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IRS1—polycystic ovary syndrome	3.17e-06	2.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IRS1—polycystic ovary syndrome	3.17e-06	2.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	3.15e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.15e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—INS—polycystic ovary syndrome	3.14e-06	2.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	3.13e-06	2.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.13e-06	2.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.1e-06	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.1e-06	2.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.07e-06	2.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	3.07e-06	2.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.07e-06	2.89e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.05e-06	2.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.05e-06	2.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—INS—polycystic ovary syndrome	3.03e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—INS—polycystic ovary syndrome	3.03e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.03e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT2—polycystic ovary syndrome	3.03e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.03e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.03e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.02e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.02e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	2.98e-06	2.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.97e-06	2.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.97e-06	2.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	2.96e-06	2.79e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.94e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	2.94e-06	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	2.93e-06	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT2—polycystic ovary syndrome	2.93e-06	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT2—polycystic ovary syndrome	2.93e-06	2.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	2.92e-06	2.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.91e-06	2.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	2.9e-06	2.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SERPINE1—polycystic ovary syndrome	2.88e-06	2.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.88e-06	2.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	2.88e-06	2.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.88e-06	2.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—BCL2—polycystic ovary syndrome	2.87e-06	2.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.87e-06	2.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.87e-06	2.7e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.83e-06	2.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.82e-06	2.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.82e-06	2.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.82e-06	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.79e-06	2.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SERPINE1—polycystic ovary syndrome	2.79e-06	2.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SERPINE1—polycystic ovary syndrome	2.79e-06	2.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—BCL2—polycystic ovary syndrome	2.78e-06	2.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—BCL2—polycystic ovary syndrome	2.78e-06	2.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.72e-06	2.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.71e-06	2.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.68e-06	2.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PPARG—polycystic ovary syndrome	2.68e-06	2.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—POMC—polycystic ovary syndrome	2.64e-06	2.49e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.63e-06	2.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.63e-06	2.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—INS—polycystic ovary syndrome	2.63e-06	2.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.61e-06	2.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.6e-06	2.45e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.59e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.59e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PPARG—polycystic ovary syndrome	2.59e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PPARG—polycystic ovary syndrome	2.59e-06	2.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	2.57e-06	2.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—POMC—polycystic ovary syndrome	2.56e-06	2.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—POMC—polycystic ovary syndrome	2.56e-06	2.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	2.55e-06	2.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.54e-06	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.54e-06	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—INS—polycystic ovary syndrome	2.54e-06	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—INS—polycystic ovary syndrome	2.54e-06	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.51e-06	2.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.51e-06	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.5e-06	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.49e-06	2.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	2.49e-06	2.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	2.47e-06	2.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	2.47e-06	2.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.42e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.41e-06	2.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.38e-06	2.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.35e-06	2.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.33e-06	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.33e-06	2.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.32e-06	2.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.29e-06	2.16e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.24e-06	2.11e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.22e-06	2.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.22e-06	2.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.22e-06	2.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.21e-06	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.21e-06	2.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	2.2e-06	2.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.19e-06	2.06e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.18e-06	2.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.16e-06	2.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.14e-06	2.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.14e-06	2.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-06	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-06	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.12e-06	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.12e-06	2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-06	1.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-06	1.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.05e-06	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.05e-06	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.05e-06	1.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.02e-06	1.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2e-06	1.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.98e-06	1.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.95e-06	1.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.95e-06	1.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.92e-06	1.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.87e-06	1.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.84e-06	1.74e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.83e-06	1.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.78e-06	1.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.75e-06	1.64e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.65e-06	1.56e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.64e-06	1.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.63e-06	1.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.57e-06	1.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.57e-06	1.48e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.54e-06	1.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.54e-06	1.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.52e-06	1.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—polycystic ovary syndrome	1.48e-06	1.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—polycystic ovary syndrome	1.44e-06	1.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—polycystic ovary syndrome	1.44e-06	1.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.39e-06	1.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.39e-06	1.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—polycystic ovary syndrome	1.37e-06	1.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	1.37e-06	1.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.34e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.34e-06	1.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—polycystic ovary syndrome	1.33e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—polycystic ovary syndrome	1.33e-06	1.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.3e-06	1.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.27e-06	1.2e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.25e-06	1.18e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.23e-06	1.16e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.23e-06	1.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.13e-06	1.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.05e-06	9.91e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	9.6e-07	9.04e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.29e-07	8.74e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	9.29e-07	8.74e-06	CbGpPWpGaD
